10 Nov 20 | All | Samsung Bioepis | Samsung Bioepis announces it has commenced Ph I trials for SB16 (proposed denosumab biosimilar).

09 Nov 20 | All | Shanghai Henlius Biotech | Shanghai Henlius Biotech announces it has commenced Ph I trials for HLX14 (proposed denosuma...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags